• SOLIFENACIN CHEMBL1734 FDA Approved

    Alternate Names:

    Solifenacin
    Vesicare
    242478-37-1
    1-AZABICYCLO[2.2.2]OCT-8-YL (1S)-1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLATE
    SOLIFENACIN [INN:BAN]
    CID443938
    SOLIFENACIN (INN)
    216457
    LS-183550
    D08522
    UNII-A8910SQJ1U
    AR-1L5425
    12015109
    2(1H)-ISOQUINOLINECARBOXYLIC ACID, 3,4-DIHYDRO-1-PHENYL-,1-AZABICYCLO(2.2.2)OCT-3-YL ESTER, (R-(R*,S*))-
    QUINUCLIDIN-3'-YL-1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE-2-CARBOXYLATEMONOSUCCINATE
    YM-53705
    YM-67905
    UNII-KKA5DLD701
    SOLIFENACIN SUCCINATE
    DAP001129
    CID216457
    VESIKUR
    242478-38-2
    AC1Q5VRD
    BUTANEDIOIC ACID, CMPD. WITH (1S)-(3R)-1-AZABICYCLO(2.2.2)OCT-3-YL 3,4-DIHYDRO-1-PHENYL-2(1H)-ISOQUINOLINECARBOXYLATE (1:1)
    MOLPORT-003-850-268
    DB01591
    2(1H)-ISOQUINOLINECARBOXYLIC ACID, 3,4-DIHYDRO-1-PHENYL-, (3R)-1-AZABICYCLO(2.2.2)OCT-3-YL ESTER, (1S)-, BUTANEDIOATE (1:1)
    YM 905
    SOLIFENACIN SUCCINATE [USAN]
    AC1L4BM3
    CID154059
    YM-905
    AC1L9FFR
    CHEMBL1200803
    [(3R)-1-AZABICYCLO[2.2.2]OCTAN-3-YL] (1S)-1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLATE
    BUTANEDIOIC ACID, COMPD WITH (1S)-(3R)-1-AZABICYCLO(2.2.2)OCT-3-YL 3,4-DIHYDRO-1-PHENYL-2(1H)-ISOQUINOLINECARBOXYLATE (1:1)
    NCGC00168778-01
    AC1L50Q6
    1-AZABICYCLO[2.2.2]OCTAN-3-YL (1S)-1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLATE
    187051786
    7483
    BUTANEDIOIC ACID; 1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID 1-AZABICYCLO[2.2.2]OCTAN-3-YL ESTER
    1-AZABICYCLO[2.2.2]OCTAN-3-YL 1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLATE; BUTANEDIOIC ACID
    23154427
    SCHEMBL6478242
    A817166

    Drug Info:

    FDA Approval approved
    Drug Indications for treatment of incontinence
    Drug Class Small Molecule
    Year of Approval 2004
    Drug Class antispasmodics
    (1 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name Solifenacin succinate, YM-905,Vesicare
    Novel drug target Established target
    Specific Action of the Ligand Antagonist

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name Solifenacin succinate, YM-905,Vesicare
    Novel drug target Established target
    Specific Action of the Ligand Antagonist

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    SOLIFENACIN Primary Drug Name

    Drug Info:
    Drug Class antispasmodics
    Year of Approval 2004

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Class Small Molecule
    Drug Indications for treatment of incontinence
    FDA Approval approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    1-AZABICYCLO[2.2.2]OCTAN-3-YL (1S)-1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLATE Drug Synonym
    AC1L50Q6 Drug Synonym
    NCGC00168778-01 Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    SOLIFENACIN GuideToPharmacology Ligand Name
    187051786 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    A817166 Drug Synonym
    SCHEMBL6478242 Drug Synonym
    242478-38-2 pubchem_primary_name

    Drug Info:

    Publications: